OverviewChartNewsTraderScreen

Cognition Therapeutics/  US19243B1026  /

IEX
2024-05-01  9:57:52 PM Chg. +0.05 Volume Bid- Ask- High Low
1.97USD +2.60% 770
Turnover: 1,534.03		 -Bid Size: - -Ask Size: - 2.03 1.94
GlobeNewswire 04-29 Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate D...
GlobeNewswire 04-22 Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Op...
GlobeNewswire 04-02 Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
GlobeNewswire 04-01 Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on...
GlobeNewswire 03-26 Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire 03-15 Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
GlobeNewswire 03-14 Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
GlobeNewswire 03-12 Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
GlobeNewswire 03-11 Cognition Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire 03-06 Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatmen...
GlobeNewswire 02-26 Cognition Therapeutics to Present at the TD Cowen Health Care Conference
GlobeNewswire 02-06 New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism ...
GlobeNewswire 01-04 Cognition Therapeutics CEO Issues Letter to Shareholders
GlobeNewswire 2023-11-16 Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantit...
GlobeNewswire 2023-11-15 Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor M...
GlobeNewswire 2023-11-07 Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alz...
GlobeNewswire 2023-11-02 Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-10-27 Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation o...
GlobeNewswire 2023-10-24 Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderat...
GlobeNewswire 2023-10-16 Cognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple ...
GlobeNewswire 2023-09-07 Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the ...
GlobeNewswire 2023-08-30 Cognition Therapeutics Announces Participation in Upcoming September Conferences
GlobeNewswire 2023-08-29 Faron Reports Half-Year Financial Results, January 1 – June 30, 2023
GlobeNewswire 2022-03-22 Cognition Therapeutics to Report Fourth Quarter and Full Year 2021 Results
GlobeNewswire 2022-03-10 Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheime...